Search

Ghandi, M., F. W. Huang, J. Jane-Valbuena, G. V. Kryukov, C. C. Lo, 3rd McDonald E. R., J. Barretina, et al. 2019. “Next-Generation Characterization of the Cancer Cell Line Encyclopedia”. Nature 569: 503-8.

Golub, T. R., A. Goga, G. F. Barker, D. E. Afar, J. McLaughlin, S. K. Bohlander, J. D. Rowley, O. N. Witte, and D. G. Gilliland. 1996. “Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia”. Mol Cell Biol 16: 4107-16.

Gustafsdottir, S. M., V. Ljosa, K. L. Sokolnicki, J. Anthony Wilson, D. Walpita, M. M. Kemp, K. Petri Seiler, et al. 2013. “Multiplex Cytological Profiling Assay to Measure Diverse Cellular States”. PLoS One 8: e80999.

Hahn, C. K., J. E. Berchuck, K. N. Ross, R. M. Kakoza, K. Clauser, A. C. Schinzel, L. Ross, et al. 2009. “Proteomic and Genetic Approaches Identify Syk As an AML Target”. Cancer Cell 16: 281-94.

Hahn, C. K., K. N. Ross, I. M. Warrington, R. Mazitschek, C. M. Kanegai, R. D. Wright, A. L. Kung, T. R. Golub, and K. Stegmaier. 2008. “Expression-Based Screening Identifies the Combination of Histone Deacetylase Inhibitors and Retinoids for Neuroblastoma Differentiation”. Proc Natl Acad Sci U S A 105: 9751-6.

Ikeda, S., A. He, S. W. Kong, J. Lu, R. Bejar, N. Bodyak, K. H. Lee, et al. 2009. “MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes”. Mol Cell Biol 29: 2193-204.

Jalili, A., C. Wagner, M. Pashenkov, G. Pathria, K. D. Mertz, H. R. Widlund, M. Lupien, et al. 2012. “Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma”. J Natl Cancer Inst 104: 1673-9.

Keenan, A. B., S. L. Jenkins, K. M. Jagodnik, S. Koplev, E. He, D. Torre, Z. Wang, et al. 2018. “The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations”. Cell Syst 6: 13-24.

Kim, E., N. Ilic, Y. Shrestha, L. Zou, A. Kamburov, C. Zhu, X. Yang, et al. 2016. “Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles”. Cancer Discov 6: 714-26.

Lin, W. M., A. C. Baker, R. Beroukhim, W. Winckler, W. Feng, J. M. Marmion, E. Laine, et al. 2008. “Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma”. Cancer Res 68: 664-73.